General Information of the Compound
Compound ID
CP0509987
Compound Name
3-(4,4-bis(4-fluorophenyl)-4,5-dihydro-1H-imidazol-2-yl)pyridazine
    Show/Hide
Structure
Formula
C19H14F2N4
Molecular Weight
336.345
Canonical SMILES
Fc1ccc(cc1)C1(CNC(=N1)c1cccnn1)c1ccc(F)cc1
    Show/Hide
InChI
InChI=1S/C19H14F2N4/c20-15-7-3-13(4-8-15)19(14-5-9-16(21)10-6-14)12-22-18(24-19)17-2-1-11-23-25-17/h1-11H,12H2,(H,22,24)
    Show/Hide
InChIKey
TXFIJHXRYWWMBF-UHFFFAOYSA-N
Physicochemical Property
logP
3.0484
Rotatable Bonds
3
Heavy Atom Count
25
Polar Areas
50.17
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9880873
SID: 14846996
ChEMBL ID
CHEMBL523338
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01795, Neuropeptide Y receptor type 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000440 LM Homo sapiens (Human)  1
1
IC50 = 560 nM
   TI
   LI
   LO
   TS